SREBF1 and hepatocellular carcinoma: WB results showed that the SREBF1-related lipid metabolism axis was significantly suppressed in HCC cells subjected to combined RG3 and CTD treatment, whereas PRMT1 overexpression notably attenuated this suppressive effect (Fig. 5F, G).